Ziopharm Oncology
ZIOP
#8592
Rank
C$0.25 B
Marketcap
C$1.19
Share price
-0.88%
Change (1 day)
-76.15%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -C$0.12 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are C$3.73 Million. In 2020 the company made an earning of -C$0.11 Billion a decrease over its 2019 earnings that were of -C$79.1 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$0.12 Billion2.37%
2020-C$0.11 Billion38.89%
2019-C$79.1 Million7.33%
2018-C$73.7 Million0.77%
2017-C$73.14 Million-67.64%
2016-C$0.23 Billion37.64%
2015-C$0.17 Billion176.1%
2014-C$59.47 Million-24.63%
2013-C$78.91 Million-43.51%
2012-C$0.14 Billion43.09%
2011-C$97.62 Million190.88%
2010-C$33.56 Million102.46%
2009-C$16.58 Million-52.68%
2008-C$35.03 Million-10.33%
2007-C$39.06 Million15.35%
2006-C$33.87 Million355.36%
2005-C$7.44 Million13788.35%
2004-C$0.06 Million9.27%
2003-C$0.05 Million-10.26%
2002-C$0.06 Million-59.35%
2001-C$0.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.27 B-9,334.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.98 B-9,098.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-C$3.77 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.37 Billion 202.45%๐Ÿ‡บ๐Ÿ‡ธ USA